Sunday, March 19, 2017

ACC: Novel Drug Fails to Reduce Post-Op Risks

(MedPage Today) -- A calcium sensitizer flops in study aimed at cutting post-op risks
via ACC: Novel Drug Fails to Reduce Post-Op Risks
by

No comments:

Post a Comment